Literature DB >> 11964177

Inhibition of cell growth through inactivation of eukaryotic translation initiation factor 5A (eIF5A) by deoxyspergualin.

Kazuhiro Nishimura1, Yuji Ohki, Tomomi Fukuchi-Shimogori, Kaori Sakata, Kan Saiga, Takanobu Beppu, Akira Shirahata, Keiko Kashiwagi, Kazuei Igarashi.   

Abstract

The mechanism of inhibition of cell growth by deoxyspergualin was studied using mouse mammary carcinoma FM3A cells. Results of studies using deoxyspergualin analogues showed that both the guanidinoheptanate amide and glyoxyspermidine moieties of deoxyspergualin were necessary to cause inhibition of cell growth. When deoxyspergualin was added to the medium, there was a strong inhibition of cell growth and formation of active eukaryotic translation initiation factor 5A (eIF5A) at the third day of culture. There was also a marked decrease in cellular putrescine content and a small decrease in spermidine content. Accumulation of decapped mRNA, which is typically associated with eIF5A deficiency in yeast, was also observed. The inhibition of cell growth and the formation of active eIF5A was not reversed by addition of spermidine. The activity of deoxyhypusine synthase, the first enzyme in the formation of active eIF5A, was inhibited by deoxyspergualin in a cell-free system. These results, taken together, indicate that inhibition of active eIF5A formation is strongly involved in the inhibition of cell growth by deoxyspergualin.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11964177      PMCID: PMC1222529          DOI: 10.1042/0264-6021:3630761

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  44 in total

1.  Relationship among activation of the Na+/H+ antiporter, ornithine decarboxylase induction, and DNA synthesis.

Authors:  Y Kakinuma; Y Sakamaki; K Ito; E J Cragoe; K Igarashi
Journal:  Arch Biochem Biophys       Date:  1987-11-15       Impact factor: 4.013

2.  Comparison of the biological effects of four irreversible inhibitors of ornithine decarboxylase in two murine lymphocytic leukemia cell lines.

Authors:  P J Pera; D L Kramer; J R Sufrin; C W Porter
Journal:  Cancer Res       Date:  1986-03       Impact factor: 12.701

3.  Preclinical antitumor activity and pharmacological properties of deoxyspergualin.

Authors:  J Plowman; S D Harrison; M W Trader; D P Griswold; M Chadwick; M F McComish; D M Silveira; D Zaharko
Journal:  Cancer Res       Date:  1987-02-01       Impact factor: 12.701

4.  Suppression of tissue graft rejection by spergualin.

Authors:  H Umezawa; M Ishizuka; T Takeuchi; F Abe; K Nemoto; K Shibuya; T Nakamura
Journal:  J Antibiot (Tokyo)       Date:  1985-02       Impact factor: 2.649

5.  Structure of an antitumor antibiotic, spergualin.

Authors:  H Umezawa; S Kondo; H Iinuma; S Kunimoto; Y Ikeda; H Iwasawa; D Ikeda; T Takeuchi
Journal:  J Antibiot (Tokyo)       Date:  1981-12       Impact factor: 2.649

6.  Synthesis and antitumor activity of spergualin analogues. II. Chemical modification of the spermidine moiety.

Authors:  Y Umeda; M Moriguchi; H Kuroda; T Nakamura; A Fujii; H Iinuma; T Takeuchi; H Umezawa
Journal:  J Antibiot (Tokyo)       Date:  1987-09       Impact factor: 2.649

7.  Formation of a compensatory polyamine by Escherichia coli polyamine-requiring mutants during growth in the absence of polyamines.

Authors:  K Igarashi; K Kashiwagi; H Hamasaki; A Miura; T Kakegawa; S Hirose; S Matsuzaki
Journal:  J Bacteriol       Date:  1986-04       Impact factor: 3.490

8.  The phosphorylation of ribosomal protein S6 in rat tissues following cycloheximide injection, in diabetes, and after denervation of diaphragm. A simple immunological determination of the extent of S6 phosphorylation on protein blots.

Authors:  P J Nielsen; K L Manchester; H Towbin; J Gordon; G Thomas
Journal:  J Biol Chem       Date:  1982-10-25       Impact factor: 5.157

9.  Immunosuppressive activities of deoxyspergualin. II. The effect on the antibody responses.

Authors:  M Makino; M Fujiwara; H Watanabe; T Aoyagi; H Umezawa
Journal:  Immunopharmacology       Date:  1987 Oct-Nov

10.  Synthesis and antitumor activity of spergualin analogues. I. Chemical modification of 7-guanidino-3-hydroxyacyl moiety.

Authors:  Y Umeda; M Moriguchi; H Kuroda; T Nakamura; H Iinuma; T Takeuchi; H Umezawa
Journal:  J Antibiot (Tokyo)       Date:  1985-07       Impact factor: 2.649

View more
  11 in total

Review 1.  The Chemical Biology of Molecular Chaperones--Implications for Modulation of Proteostasis.

Authors:  Kristoffer R Brandvold; Richard I Morimoto
Journal:  J Mol Biol       Date:  2015-05-21       Impact factor: 5.469

2.  Evaluation of deoxyhypusine synthase inhibitors targeting BCR-ABL positive leukemias.

Authors:  Patrick Ziegler; Tuhama Chahoud; Thomas Wilhelm; Nora Pällman; Melanie Braig; Valeska Wiehle; Susanne Ziegler; Marcus Schröder; Chris Meier; Adrian Kolodzik; Matthias Rarey; Jens Panse; Joachim Hauber; Stefan Balabanov; Tim H Brümmendorf
Journal:  Invest New Drugs       Date:  2012-03-14       Impact factor: 3.850

3.  Independent roles of eIF5A and polyamines in cell proliferation.

Authors:  Kazuhiro Nishimura; Kaori Murozumi; Akira Shirahata; Myung Hee Park; Keiko Kashiwagi; Kazuei Igarashi
Journal:  Biochem J       Date:  2005-02-01       Impact factor: 3.857

4.  Treatment of active lupus nephritis with the novel immunosuppressant 15-deoxyspergualin: an open-label dose escalation study.

Authors:  Hanns-Martin Lorenz; Wilhelm H Schmitt; Vladimir Tesar; Ulf Müller-Ladner; Ingo Tarner; Ingeborg A Hauser; Falk Hiepe; Tobias Alexander; Heike Woehling; Kyuichi Nemoto; Peter A Heinzel
Journal:  Arthritis Res Ther       Date:  2011-03-01       Impact factor: 5.156

5.  Biochemical quantitation of the eIF5A hypusination in Arabidopsis thaliana uncovers ABA-dependent regulation.

Authors:  Borja Belda-Palazón; María A Nohales; José L Rambla; José L Aceña; Oscar Delgado; Santos Fustero; M Carmen Martínez; Antonio Granell; Juan Carbonell; Alejandro Ferrando
Journal:  Front Plant Sci       Date:  2014-05-16       Impact factor: 5.753

6.  Inhibition of Eukaryotic Translation Initiation Factor 5A (eIF5A) Hypusination Suppress p53 Translation and Alters the Association of eIF5A to the Ribosomes.

Authors:  Marianna Martella; Caterina Catalanotto; Claudio Talora; Anna La Teana; Paola Londei; Dario Benelli
Journal:  Int J Mol Sci       Date:  2020-06-27       Impact factor: 5.923

7.  An intercellular polyamine transfer via gap junctions regulates proliferation and response to stress in epithelial cells.

Authors:  Bénédicte Desforges; Patrick A Curmi; Ouissame Bounedjah; Samir Nakib; Loic Hamon; Jean-Pascal De Bandt; David Pastré
Journal:  Mol Biol Cell       Date:  2013-03-20       Impact factor: 4.138

8.  Transcriptional oncogenomic hot spots in Barrett's adenocarcinomas: serial analysis of gene expression.

Authors:  Mohammad H Razvi; Dunfa Peng; Altaf A Dar; Steven M Powell; Henry F Frierson; Christopher A Moskaluk; Kay Washington; Wael El-Rifai
Journal:  Genes Chromosomes Cancer       Date:  2007-10       Impact factor: 5.006

9.  New Series of Potent Allosteric Inhibitors of Deoxyhypusine Synthase.

Authors:  Yuta Tanaka; Osamu Kurasawa; Akihiro Yokota; Michael G Klein; Bunnai Saito; Shigemitsu Matsumoto; Masanori Okaniwa; Geza Ambrus-Aikelin; Noriko Uchiyama; Daisuke Morishita; Hiromichi Kimura; Shinichi Imamura
Journal:  ACS Med Chem Lett       Date:  2020-07-30       Impact factor: 4.345

Review 10.  The eukaryotic initiation factor 5A (eIF5A1), the molecule, mechanisms and recent insights into the pathophysiological roles.

Authors:  Michel Tauc; Marc Cougnon; Romain Carcy; Nicolas Melis; Thierry Hauet; Luc Pellerin; Nicolas Blondeau; Didier F Pisani
Journal:  Cell Biosci       Date:  2021-12-24       Impact factor: 7.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.